Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q4 EPS of ($0.39), $0.02 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $3.56 million versus the consensus estimate of $3.95 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.